Houda Alachkar

Title(s)Associate Professor of Clinical Pharmacy
SchoolUSC School of Pharmacy
Address1985 Zonal Ave.
Health Sciences Campus
Los Angeles CA 90089-9121
Phone+1 323 442 2696
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A rigorous benchmarking of alignment-based HLA typing algorithms for RNA-seq data. bioRxiv. 2024 Jan 16. Yu D, Ayyala R, Sadek SH, Chittampalli L, Farooq H, Jung J, Nahid AA, Boldirev G, Jung M, Park S, Nguyen A, Zelikovsky A, Mancuso N, Joo JWJ, Thompson RF, Alachkar H, Mangul S. PMID: 38293199; PMCID: PMC10827116.
      View in: PubMed   Mentions:
    2. Features of the TCR repertoire associate with patients' clinical and molecular characteristics in acute myeloid leukemia. Front Immunol. 2023; 14:1236514. Pospiech M, Tamizharasan M, Wei YC, Kumar AMS, Lou M, Milstein J, Alachkar H. PMID: 37928542; PMCID: PMC10620936.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Response to 'comment on rigorous benchmarking of T cell receptor repertoire profiling methods for cancer RNA sequencing' by Davydov A.N.; Bolotin D.A.; Poslavsky S. V. and Chudakov D.M. Brief Bioinform. 2023 09 22; 24(6). Huang YN, Vahed M, Peng K, Alachkar H, Mangul S. PMID: 37824736; PMCID: PMC10569746.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. Genomics and transcriptomic alterations of the glutamate receptors in acute myeloid leukemia. Clin Transl Sci. 2023 10; 16(10):1828-1841. Alqahtani A, Wang M, Lou M, Alachkar H. PMID: 37670476; PMCID: PMC10582680.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    5. Rigorous benchmarking of T-cell receptor repertoire profiling methods for cancer RNA sequencing. Brief Bioinform. 2023 07 20; 24(4). Peng K, Nowicki TS, Campbell K, Vahed M, Peng D, Meng Y, Nagareddy A, Huang YN, Karlsberg A, Miller Z, Brito J, Nadel B, Pak VM, Abedalthagafi MS, Burkhardt AM, Alachkar H, Ribas A, Mangul S. PMID: 37291798; PMCID: PMC10359085.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    6. Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment. Cell Mol Biol Lett. 2023 May 24; 28(1):45. Meng Y, Pospiech M, Ali A, Chandwani R, Vergel M, Onyemaechi S, Yaghmour G, Lu R, Alachkar H. PMID: 37226083; PMCID: PMC10210361.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    7. Profiling the epigenetic landscape of the antigen receptor repertoire: the missing epi-immunogenomics data. Nat Methods. 2023 04; 20(4):477-481. Aburajab R, Pospiech M, Alachkar H. PMID: 36522502.
      View in: PubMed   Mentions: 1     Fields:    
    8. Prediction of Peptide and TCR CDR3 Loops in Formation of Class I MHC-Peptide-TCR Complexes Using Molecular Models with Solvation. Methods Mol Biol. 2023; 2673:273-287. Mehta NM, Li Y, Patel V, Li W, Morningstar-Kywi N, Pospiech M, Alachkar H, Haworth IS. PMID: 37258921.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    9. Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding. Expert Opin Drug Metab Toxicol. 2023 Jan-Jun; 19(6):357-366. Alqahtani A, Alhousari D, Ali A, Yaghmour G, Orgel E, Curran E, Stock W, Bhojwani D, Alachkar H. PMID: 37410014.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. pyTCR: A comprehensive and scalable solution for TCR-Seq data analysis to facilitate reproducibility and rigor of immunogenomics research. Front Immunol. 2022; 13:954078. Peng K, Moore J, Vahed M, Brito J, Kao G, Burkhardt AM, Alachkar H, Mangul S. PMID: 36451811; PMCID: PMC9704496.
      View in: PubMed   Mentions: 2     Fields:    
    11. Hispanic ethnicity and the rs4880 variant in SOD2 are associated with elevated liver enzymes and bilirubin levels in children receiving asparaginase-containing chemotherapy for acute lymphoblastic leukemia. Biomed Pharmacother. 2022 Jun; 150:113000. Wu S, Wang M, Alqahtani A, Lou M, Stock W, Bhojwani D, Alachkar H. PMID: 35658244; PMCID: PMC9450009.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. CD99 in malignant hematopoiesis. Exp Hematol. 2022 02; 106:40-46. Ali A, Vaikari VP, Alachkar H. PMID: 34920053; PMCID: PMC9450008.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    13. Ancestral diversity is limited in published T cell receptor sequencing studies. Immunity. 2021 10 12; 54(10):2177-2179. Huang YN, Peng K, Popejoy AB, Hu J, Nowicki TS, Gold SM, Quintana-Murci L, Fuentes-Guajardo M, Shugay M, Greiff V, Burkhardt AM, Alachkar H, Mangul S. PMID: 34644550.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Diversity in immunogenomics: the value and the challenge. Nat Methods. 2021 06; 18(6):588-591. Peng K, Safonova Y, Shugay M, Popejoy AB, Rodriguez OL, Breden F, Brodin P, Burkhardt AM, Bustamante C, Cao-Lormeau VM, Corcoran MM, Duffy D, Fuentes-Guajardo M, Fujita R, Greiff V, Jönsson VD, Liu X, Quintana-Murci L, Rossetti M, Xie J, Yaari G, Zhang W, Abedalthagafi MS, Adekoya KO, Ahmed RA, Chang WC, Gray C, Nakamura Y, Lees WD, Khatri P, Alachkar H, Scheepers C, Watson CT, Karlsson Hedestam GB, Mangul S. PMID: 34002093; PMCID: PMC8842483.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    15. Deregulation of apolipoprotein C2 gene in cancer: A potential metabolic vulnerability. Clin Transl Med. 2021 06; 11(6):e406. Liu Y, Meng Y, Zhang T, Alachkar H. PMID: 34185418; PMCID: PMC8161511.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    16. Profiling of T Cell Repertoire in SARS-CoV-2-Infected COVID-19 Patients Between Mild Disease and Pneumonia. J Clin Immunol. 2021 08; 41(6):1131-1145. Chang CM, Feng PH, Wu TH, Alachkar H, Lee KY, Chang WC. PMID: 33950324; PMCID: PMC8096628.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    17. Strategies targeting FLT3 beyond the kinase inhibitors. Pharmacol Ther. 2021 09; 225:107844. Almatani MF, Ali A, Onyemaechi S, Zhao Y, Gutierrez L, Vaikari VP, Alachkar H. PMID: 33811956.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia. Blood Cancer J. 2021 03 03; 11(3):48. Eisfelder BJ, Saygin C, Wynne J, Colton MW, Fischietti M, Beauchamp EM, Cheng JX, Odenike O, Roboz G, Alachkar H, Stock W. PMID: 33658483; PMCID: PMC7930094.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    19. Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia. Blood Cancer Discov. 2020 09; 1(2):198-213. Zhang T, Yang J, Vaikari VP, Beckford JS, Wu S, Akhtari M, Alachkar H. PMID: 32944714; PMCID: PMC7494214.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    20. Deciphering the TCR Repertoire to Solve the COVID-19 Mystery. Trends Pharmacol Sci. 2020 08; 41(8):518-530. Gutierrez L, Beckford J, Alachkar H. PMID: 32576386; PMCID: PMC7305739.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    21. Anti-CD99 scFv-ELP nanoworms for the treatment of acute myeloid leukemia. Nanomedicine. 2020 10; 29:102236. Vaikari VP, Park M, Keossayan L, MacKay JA, Alachkar H. PMID: 32535112; PMCID: PMC7508895.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    22. Anti-FLT3 nanoparticles for acute myeloid leukemia: Preclinical pharmacology and pharmacokinetics. J Control Release. 2020 08 10; 324:317-329. Park M, Vaikari VP, Lam AT, Zhang Y, MacKay JA, Alachkar H. PMID: 32428520; PMCID: PMC7473778.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimals
    23. Human Granulocyte-Macrophage Colony-Stimulating Factor Fused to Elastin-Like Polypeptides Assembles Biologically-Active Nanoparticles. Bioconjug Chem. 2020 05 20; 31(5):1551-1561. Park M, Vaikari VP, Dhandhukia JP, Alachkar H, MacKay JA. PMID: 32319752; PMCID: PMC7489497.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia. Haematologica. 2020 04; 105(4):999-1012. Vaikari VP, Du Y, Wu S, Zhang T, Metzeler K, Batcha AMN, Herold T, Hiddemann W, Akhtari M, Alachkar H. PMID: 31371417; PMCID: PMC7109747.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    25. CD97 expression is associated with poor overall survival in acute myeloid leukemia. Exp Hematol. 2019 07; 75:64-73.e4. Vaikari VP, Yang J, Wu S, Alachkar H. PMID: 31260716; PMCID: PMC7473776.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Characterization of upregulated adhesion GPCRs in acute myeloid leukemia. Transl Res. 2019 10; 212:26-35. Yang J, Wu S, Alachkar H. PMID: 31153896; PMCID: PMC7473775.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    27. The mitochondrial transcription machinery genes are upregulated in acute myeloid leukemia and associated with poor clinical outcome. Metabol Open. 2019 Jun; 2:100009. Wu S, Fahmy N, Alachkar H. PMID: 32812906; PMCID: PMC7424792.
      View in: PubMed   Mentions: 6  
    28. Midostaurin reduces Regulatory T cells markers in Acute Myeloid Leukemia. Sci Rep. 2018 12 03; 8(1):17544. Gutierrez L, Jang M, Zhang T, Akhtari M, Alachkar H. PMID: 30510164; PMCID: PMC6277419.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    29. Clinical and laboratory features of seventy-eight UK patients with Good's syndrome (thymoma and hypogammaglobulinaemia). Clin Exp Immunol. 2019 01; 195(1):132-138. Zaman M, Huissoon A, Buckland M, Patel S, Alachkar H, Edgar JD, Thomas M, Arumugakani G, Baxendale H, Burns S, Williams AP, Jolles S, Herriot R, Sargur RB, Arkwright PD. PMID: 30216434; PMCID: PMC6300645.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    30. Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia. Sci Rep. 2018 09 05; 8(1):13301. Wu S, Akhtari M, Alachkar H. PMID: 30185817; PMCID: PMC6125587.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    31. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. J Transl Med. 2018 06 20; 16(1):170. Wu S, Du Y, Beckford J, Alachkar H. PMID: 29925392; PMCID: PMC6009962.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    32. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018 06; 192(3):284-291. Shillitoe B, Bangs C, Guzman D, Gennery AR, Longhurst HJ, Slatter M, Edgar DM, Thomas M, Worth A, Huissoon A, Arkwright PD, Jolles S, Bourne H, Alachkar H, Savic S, Kumararatne DS, Patel S, Baxendale H, Noorani S, Yong PFK, Waruiru C, Pavaladurai V, Kelleher P, Herriot R, Bernatonienne J, Bhole M, Steele C, Hayman G, Richter A, Gompels M, Chopra C, Garcez T, Buckland M. PMID: 29878323; PMCID: PMC5980391.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    33. The era of immunogenomics/immunopharmacogenomics. J Hum Genet. 2018 Jul; 63(8):865-875. Zewde M, Kiyotani K, Park JH, Fang H, Yap KL, Yew PY, Alachkar H, Kato T, Mai TH, Ikeda Y, Matsuda T, Liu X, Ren L, Deng B, Harada M, Nakamura Y. PMID: 29785006.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection. BMC Nephrol. 2016 11 21; 17(1):181. Alachkar H, Mutonga M, Kato T, Kalluri S, Kakuta Y, Uemura M, Imamura R, Nonomura N, Vujjini V, Alasfar S, Rabb H, Nakamura Y, Alachkar N. PMID: 27871261; PMCID: PMC5117555.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    35. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. Pharmacogenomics J. 2017 06; 17(3):274-279. Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson RA, Bloomfield CD, Marcucci G, Nakamura Y, Stock W. PMID: 27019981; PMCID: PMC5089920.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    36. SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells. Oncotarget. 2015 Dec 22; 6(41):43162-71. Vougiouklakis T, Sone K, Saloura V, Cho HS, Suzuki T, Dohmae N, Alachkar H, Nakamura Y, Hamamoto R. PMID: 26586479; PMCID: PMC4791223.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    37. T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia. Oncotarget. 2015 Oct 20; 6(32):33410-25. Alachkar H, Mutonga M, Malnassy G, Park JH, Fulton N, Woods A, Meng L, Kline J, Raca G, Odenike O, Takamatsu N, Miyamoto T, Matsuo Y, Stock W, Nakamura Y. PMID: 26450903; PMCID: PMC4741775.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    38. Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL). Transl Oncol. 2015 Oct; 8(5):368-375. Mutonga M, Tamura K, Malnassy G, Fulton N, de Albuquerque A, Hamamoto R, Stock W, Nakamura Y, Alachkar H. PMID: 26500027; PMCID: PMC4631083.
      View in: PubMed   Mentions: 13  
    39. Deep-sequencing of the T-cell receptor repertoire in patients with haplo-cord and matched-donor transplants. Chimerism. 2015 Jul 03; 6(3):47-9. Alachkar H, Nakamura Y. PMID: 26745665; PMCID: PMC5154355.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    40. Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2015 Sep; 50(9):1227-34. Yew PY, Alachkar H, Yamaguchi R, Kiyotani K, Fang H, Yap KL, Liu HT, Wickrema A, Artz A, van Besien K, Imoto S, Miyano S, Bishop MR, Stock W, Nakamura Y. PMID: 26052909; PMCID: PMC4559843.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCellsCTClinical Trials
    41. Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia. Leukemia. 2015 Oct; 29(10):1981-92. Khalife J, Radomska HS, Santhanam R, Huang X, Neviani P, Saultz J, Wang H, Wu YZ, Alachkar H, Anghelina M, Dorrance A, Curfman J, Bloomfield CD, Medeiros BC, Perrotti D, Lee LJ, Lee RJ, Caligiuri MA, Pichiorri F, Croce CM, Garzon R, Guzman ML, Mendler JH, Marcucci G. PMID: 25971362; PMCID: PMC4868182.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    42. Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe. J Clin Immunol. 2015 Feb; 35(2):199-205. Turley AJ, Gathmann B, Bangs C, Bradbury M, Seneviratne S, Gonzalez-Granado LI, Hackett S, Kutukculer N, Alachkar H, Hambleton S, Ritterbusch H, Kralickova P, Marodi L, Seidel MG, Dueckers G, Roesler J, Huissoon A, Baxendale H, Litzman J, Arkwright PD. PMID: 25663093.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    43. Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia. Oncotarget. 2014 Dec 15; 5(23):12371-82. Alachkar H, Mutonga MB, Metzeler KH, Fulton N, Malnassy G, Herold T, Spiekermann K, Bohlander SK, Hiddemann W, Matsuo Y, Stock W, Nakamura Y. PMID: 25365263; PMCID: PMC4323011.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    44. TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis. Sci Transl Med. 2014 Oct 22; 6(259):259ra145. Matsuo Y, Park JH, Miyamoto T, Yamamoto S, Hisada S, Alachkar H, Nakamura Y. PMID: 25338756.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    45. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Mol Cancer Res. 2015 Feb; 13(2):293-304. Saloura V, Cho HS, Kiyotani K, Alachkar H, Zuo Z, Nakakido M, Tsunoda T, Seiwert T, Lingen M, Licht J, Nakamura Y, Hamamoto R. PMID: 25280969.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    46. SPARC promotes leukemic cell growth and predicts acute myeloid leukemia outcome. J Clin Invest. 2014 Apr; 124(4):1512-24. Alachkar H, Santhanam R, Maharry K, Metzeler KH, Huang X, Kohlschmidt J, Mendler JH, Benito JM, Hickey C, Neviani P, Dorrance AM, Anghelina M, Khalife J, Tarighat SS, Volinia S, Whitman SP, Paschka P, Hoellerbauer P, Wu YZ, Han L, Bolon BN, Blum W, Mrózek K, Carroll AJ, Perrotti D, Andreeff M, Caligiuri MA, Konopleva M, Garzon R, Bloomfield CD, Marcucci G. PMID: 24590286; PMCID: PMC3973087.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    47. A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol. 2014 Jan; 175(1):59-67. Jolles S, Williams P, Carne E, Mian H, Huissoon A, Wong G, Hackett S, Lortan J, Platts V, Longhurst H, Grigoriadou S, Dempster J, Deacock S, Khan S, Darroch J, Simon C, Thomas M, Pavaladurai V, Alachkar H, Herwadkar A, Abinun M, Arkwright P, Tarzi M, Helbert M, Bangs C, Pastacaldi C, Phillips C, Bennett H, El-Shanawany T. PMID: 23786259; PMCID: PMC3898555.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    48. The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years' activity 2008-2012. Clin Exp Immunol. 2014 Jan; 175(1):68-78. Edgar JD, Buckland M, Guzman D, Conlon NP, Knerr V, Bangs C, Reiser V, Panahloo Z, Workman S, Slatter M, Gennery AR, Davies EG, Allwood Z, Arkwright PD, Helbert M, Longhurst HJ, Grigoriadou S, Devlin LA, Huissoon A, Krishna MT, Hackett S, Kumararatne DS, Condliffe AM, Baxendale H, Henderson K, Bethune C, Symons C, Wood P, Ford K, Patel S, Jain R, Jolles S, El-Shanawany T, Alachkar H, Herwadkar A, Sargur R, Shrimpton A, Hayman G, Abuzakouk M, Spickett G, Darroch CJ, Paulus S, Marshall SE, McDermott EM, Heath PT, Herriot R, Noorani S, Turner M, Khan S, Grimbacher B. PMID: 23841717; PMCID: PMC3898556.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    49. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol. 2013 Mar 16; 6:21. Alachkar H, Santhanam R, Harb JG, Lucas DM, Oaks JJ, Hickey CJ, Pan L, Kinghorn AD, Caligiuri MA, Perrotti D, Byrd JC, Garzon R, Grever MR, Marcucci G. PMID: 23497456; PMCID: PMC3623627.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    50. Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood. 2013 Jan 03; 121(1):159-69. Hickey CJ, Schwind S, Radomska HS, Dorrance AM, Santhanam R, Mishra A, Wu YZ, Alachkar H, Maharry K, Nicolet D, Mrózek K, Walker A, Eiring AM, Whitman SP, Becker H, Perrotti D, Wu LC, Zhao X, Fehniger TA, Vij R, Byrd JC, Blum W, Lee LJ, Caligiuri MA, Bloomfield CD, Garzon R, Marcucci G. PMID: 23100311; PMCID: PMC3538328.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    51. Determination of cellular uptake and intracellular levels of Cenersen (Aezea(®), EL625), a p53 antisense oligonucleotide in acute myeloid leukemia cells. J Pharm Biomed Anal. 2012 Dec; 71:228-32. Alachkar H, Xie Z, Marcucci G, Chan KK. PMID: 22944355; PMCID: PMC4201859.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    52. Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. Eur J Hum Genet. 2011 Jan; 19(1):76-83. Smith RM, Alachkar H, Papp AC, Wang D, Mash DC, Wang JC, Bierut LJ, Sadee W. PMID: 20700147; PMCID: PMC2995013.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    53. Allelic mRNA expression of sortilin-1 (SORL1) mRNA in Alzheimer's autopsy brain tissues. Neurosci Lett. 2008 Dec 19; 448(1):120-4. Alachkar H, Kataki M, Scharre DW, Papp A, Sadee W. PMID: 18938222; PMCID: PMC2612539.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Skin penetration and lag times of neat and aqueous diethyl phthalate, 1,2-dichloroethane and naphthalene. Cutan Ocul Toxicol. 2007; 26(2):147-60. Frasch HF, Barbero AM, Alachkar H, McDougal JN. PMID: 17612981.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    See more options in the Advanced Search tab

    Houda's Networks
    Concepts (269)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.